Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)

Официальное название

Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU): a Randomized Controlled Trial.

Обзор

The goal of this clinical trial is to evaluate whether the use of the medidux™ smartphone app can optimize post-discharge management for patients admitted to Acute Admission Units (AAU) with non-urgent health complaints. This trial includes adult patients (age ≥ 18) in Emergency Severity Index (ESI) triage system groups 4 (standard) or 5 (non-urgent), presenting with primary symptoms such as cough, back pain, or abdominal discomfort. The main question it aims to answer is: Can the medidux™ app reduce the incidence of AAU readmissions, emergency hospitalizations, or consultations with other medical providers within 7 days after initial admission? Researchers will compare participants using the medidux™ app (intervention arm) with those receiving standard care (control arm) to observe potential differences in the rates of readmissions, emergency hospitalizations, and medical consultations. Participants will: * use the medidux™ app to monitor their symptoms and vital parameters for 7 days after discharge (intervention arm). * receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions (both arms).

Вмешательства

• Устройство Smartphone Application for Post-Discharge Symptom Monitoring
  This intervention involves the use of a smartphone application designed for symptom monitoring. The app enables participants to log daily health data, including symptoms and vital signs, for 7 days following discharge. It provides automated prompts and guidance for self-management, including when to seek medical assistance. The app does not provide direct medical intervention but facilitates remote symptom tracking to reduce readmissions and emergency hospitalizations. Follow-up consultations ar

Первичные конечные точки

• Incidence of AAU Readmissions, Emergency Hospitalizations, and Consultations of Other Medical Providers within 7 (± 1) days [Срок оценки: 7 (± 1) days after the initial AAU admission]

Вторичные конечные точки (12)

• Incidence of AAU Readmissions, Emergency Hospitalizations, and Consultations of Other Medical Providers within 28 (± 1) days. [Срок оценки: 28 (± 1) days after the initial AAU admission]
• Incidence of AAU Readmissions within 7 (± 1) days [Срок оценки: 7 (± 1) days after the initial AAU admission]
• Incidence of AAU Readmissions within 28 (± 1) days [Срок оценки: 28 (± 1) days after the initial AAU admission]
• Incidence of Emergency Hospitalizations within 7 (± 1) days [Срок оценки: 7 (± 1) days after the initial AAU admission]
• Incidence of Emergency Hospitalizations within 28 (± 1) days [Срок оценки: 28 (± 1) days after the initial AAU admission]
• Incidence of Consultations of Other Medical Providers within 7 (± 1) days [Срок оценки: 7 (± 1) days after the initial AAU admission]
• Incidence of Consultations of Other Medical Providers within 28 (± 1) days [Срок оценки: 28 (± 1) days after the initial AAU admission]
• Agreement Between ePRO-Derived AE Severity Index and Physician-Assessed AE Severity [Срок оценки: 7 (± 1) days after the initial AAU admission]
• Differences Between ePRO-Derived AE Severity and Physician-Assessed AE Severity Ratings [Срок оценки: 7 (± 1) days after the initial AAU admission]
• Number of Participant-Reported Symptoms by Severity [Срок оценки: Daily over the 7 (± 1) day observation period]
• Evolution of Participant-Reported Symptoms Over Time [Срок оценки: Daily over the 7 (± 1) day observation period]
• Participant-Assessed Usability and Usefulness of the Smartphone App [Срок оценки: Day 7 (± 1) after the initial AAU admission]

Критерии участия

Критерии включения

• Signed Informed Consent Form (ICF)
• Age ≥ 18 years
• (Self-)admission to the involved Acute Admissions Unit (AAU)
• "Lead symptom" identified as coughing, back pain or abdominal discomfort
• Participant within ESI triage system group 4 (standard) and 5 (non-urgent)
• German-speaking
• Ownership of a smartphone or other mobile device with iOS or Android operating system

Критерии исключения

• Age < 18 years
• Participant whose compliance to the study's protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted
• Participant with insufficient knowledge about the use of a smartphone or other mobile device with iOS or Android operating system
• Participant already using or planning to use another comparable electronic patient-reported symptom monitoring system (e.g. CANKADO) during this trial

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Организация здравоохранения

Центры проведения

Швейцария · 1 центр

• Notfallzentrum See-Spital Horgen — Horgen

Идентификаторы

NCT: NCT06655337 · AAUEffidux

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗